I agree that this site is using cookies. You can find further informations here.
X
Taminishi-Katsuragawa, Yoko
8  results:
Search for persons X
?
1

The Rationale for the Dual-Targeting Therapy for RSK2 and A..:

Isa, Reiko ; Horinaka, Mano ; Tsukamoto, Taku...
International Journal of Molecular Sciences.  23 (2022)  6 - p. 2919 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cance:

Taminishi-Katsuragawa, Yoko ; Shimura, Yuji ; Inoue, Yu...
Internal Medicine.  61 (2022)  8 - p. 1231-1235 , 2022
Link: https://doi.org/10.2169/..
 
?
3

A retrospective analysis of treatment outcomes in 45 patien..:

Fuchida, Shin-ichi ; Ide, Daisuke ; Taminishi-Katsuragawa, Yoko...
International Journal of Hematology.  111 (2020)  6 - p. 803-811 , 2020
Link: https://doi.org/10.1007/..
 
?
4

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL ..:

Kawaji-Kanayama, Yuka ; Tsukamoto, Taku ; Nakano, Masakazu...
HemaSphere.  7 (2023)  S3 - p. e0595036 , 2023
Link: https://doi.org/10.1097/..
 
?
5

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL ..:

Kawaji-Kanayama, Yuka ; Tsukamoto, Taku ; Nakano, Masakazu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431172/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL ..:

Yuka Kawaji-Kanayama ; Taku Tsukamoto ; Masakazu Nakano...
http://journals.lww.com/10.1097/01.HS9.0000971796.05950.36.  , 2023
Link: https://doi.org/10.1097/..
 
?
7

The Rationale for the Dual-Targeting Therapy for RSK2 and A..:

Reiko Isa ; Mano Horinaka ; Taku Tsukamoto...
Molecular Oncology.  , 2022
Link: https://doi.org/10.3390/..
 
?
8

The Rationale for the Dual-Targeting Therapy for RSK2 and A..:

Reiko Isa ; Mano Horinaka ; Taku Tsukamoto...
https://www.mdpi.com/1422-0067/23/6/2919.  , 2022
Link: https://doi.org/10.3390/..
 
1-8